Maria Rovithi

20142019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2014 2019

A phase 1/2 study of intermittent, high dose sunitinib in patients with advanced solid tumors.

Rovithi, M., Labots, M., Richard, Honeywell, Ten Tije, A. J., Ruijter, R., Skardhamar, M., Peters, G. J., Voortman, J. & Verheul, H. M. W., 20 May 2017, In : Journal of Clinical Oncology. 35

Research output: Contribution to journalMeeting AbstractAcademic

Development of bioluminescent chick chorioallantoic membrane (CAM) models for primary pancreatic cancer cells: A platform for drug testing

Rovithi, M., Avan, A., Funel, N., Leon, L. G., Gomez, V. E., Wurdinger, T., Griffioen, A. W., Verheul, H. M. W. & Giovannetti, E., 17 Mar 2017, In : Scientific Reports. 7, 44686.

Research output: Contribution to journalArticleAcademicpeer-review

Insight in taste alterations during treatment with protein kinase inhibitors

van der Werf, A., Rovithi, M., Langius, J. A. E., de van der Schueren, M. A. E. & Verheul, H. M. W., 1 Nov 2017, In : European Journal of Cancer. 86, p. 125-134 10 p.

Research output: Contribution to journalReview articleAcademicpeer-review